4-8-2022Cross-posted from National Institute of Child Health and Human Development NewsroomYouth aged 13 to 24 years who were offered HIV testing by a digital health to…
3-23-2022Cross-posted from NIAID NewsroomPhase 1 Study Is Among First to Examine mRNA Technology for HIVThe National Institute of Allergy and Infectious Diseases (NIAID)…
3-1-2022As the 2022 virtual Conference on Retroviruses and Opportunistic Infections (CROI 2022) came to a close, NIH’s Dr. Carl Dieffenbach joined HIV.gov for a video…
2-17-2022In an HIV.gov video conversation yesterday, NIH’s Dr. Carl Dieffenbach discussed some of the pivotal HIV research advances presented this week at the 2022 vir…
2-15-2022Cross-posted from NIAID NewsroomWoman Has Remained Without Detectable HIV for 14 MonthsA woman with HIV who received a cord blood stem cell transplant to treat …
2-9-2022Next week, for the 11th year in a row, HIV.gov will begin sharing updates on the latest HIV research from the 2022 virtual Conference on Retroviruses and Opport…
2-7-2022Cross-posted from NIH Office of AIDS Research, Director’s CornerOn February 7th, the United States recognizes National Black HIV/AIDS Awareness Day (NBHAAD), …
1-5-2022The Panel on Treatment of HIV During Pregnancy and Prevention of Perinatal Transmission recently updated several sections of theâ¯Recommendations for the U…
12-30-2021Cross-posed from NIH Office of AIDS Research NewsroomThe NIH Office of AIDS Research is saddened by the loss of Archbishop Desmond Tutu, South Africa’s Nobel …
12-21-2021Cross-posted from NIAID NewsroomApproval Marks Pivotal Expansion of HIV Prevention Options in the United StatesYesterday the U.S. Food and Drug Administration a…
